Radius Health, a biopharmaceutical company that has commercialized an osteoporosis drug and is developing new medicines for cancer and rare diseases, has reached an agreement to be acquired by two private equity firms in an $890m deal.
Get the latest news right in your inbox. We never spam!
Pharmacy chain Walgreens and two of its former executives have agreed to pay $105 million to end investor claims the company touted overly rosy financial projections as it sought shareholder...
The talks have picked up pace and the two companies are scheduled to meet this week. Source: Merck Pushes Forward With Potential Deal for Seagen - WSJ
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme Source
Partners Group will announce today it is hiring Ben Breier, former CEO of Kindred Healthcare, who led the $1.4 billion sale of the healthcare provider to health insurer Source: Partners Group hires...